We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,327

FDA Releases 2018 Roadmap: Focus On Digital Health Continues
  • Kelley Drye & Warren LLP
  • USA
  • January 16 2018

Last week, FDA released a document outlining its policy priorities for the coming year. “Healthy Innovation, Safer Families: FDA’s 2018 Strategic


Trump Administration Outlines Planned Regulatory and Deregulatory Actions for 2018
  • Reed Smith LLP
  • USA
  • December 21 2017

The Trump Administration has updated its "Unified Agenda of Regulatory and Deregulatory Actions," which lists the scope and anticipated timing of


Cannabis in 2017: Setting the stage for legalization
  • Osler Hoskin & Harcourt LLP
  • Canada
  • December 18 2017

A groundbreaking shift in policy in 2017 set the stage for the legalization of cannabis for recreational use in Canada, which the Canadian government


Texas Telemedicine Saga Finally Over? The Texas Medical Board Substantially Revises Telemedicine Regulations
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • December 11 2017

The Texas Medical Board’s (the “Board”) adoption of new telehealth licensing regulations may finally put to bed long-running challenges to the state’s


Food & Beverage Update: Minimum Unit Pricing - Tackling Alcohol Misuse
  • Mason Hayes & Curran
  • OECD, Ireland
  • December 6 2017

The Public Health (Alcohol) 2015 (Bill) was presented in late 2015 to tackle Ireland's ongoing problem with over-consumption and misuse of alcohol


Health and Justice Annual Review 201617
  • Hill Dickinson LLP
  • United Kingdom
  • December 4 2017

Public Health England (PHE) has recently published its annual review outlining current data and evidence in relation to key public health concerns of


Legislation, Lawsuit Cloud Future of 340B Program Payment Rate Reductions
  • Jones Day
  • USA
  • December 1 2017

A Final Rule published by the Centers for Medicare & Medicaid Services carries a provision that reduces reimbursement for most 340B Program drugs


Dutch Health Council’s proposal of compulsory licensing as solution to high pharma prices
  • Bristows LLP
  • Netherlands, United Kingdom, European Union
  • November 27 2017

Shortly before becoming the new home of the EMA, the Netherlands piqued the interest of the pharma industry with a controversial move on drug pricing


Mobile health app developers take note - the importance of patient safety
  • RPC
  • USA, United Kingdom
  • November 24 2017

The benefits of mobile health apps are plenty. However, developers must be aware of their responsibility to users to ensure apps are safe and


New OIG Project Expands Telemedicine Audits to State Medicaid Programs
  • Foley & Lardner LLP
  • USA
  • November 20 2017

Following on the heels of its plans to review Medicare payments for telehealth services, the federal Office of Inspector General (OIG) at the